Product Development
Formulation strategy, R&D roadmap, raw material sourcing, stability studies, and bioequivalence coordination.
Life Sciences Platform & Advisory
The molecule dossier platform, built on 30 years of pharma experience.
Search a growing library of regulatory-ready molecule dossiers, and work with advisors who have scaled pharma businesses from Lisbon to global markets.
Or jump straight in
Advisory
Consulting, backed by operator experience
Beyond the platform, QANTARIS advises founders and pharma groups on the full lifecycle of health products.
Licensing
In-licensing and out-licensing deals, distribution rights, operating permits, and partnership structuring across markets.
Regulatory & Marketing Authorization
Dossier preparation, regulatory submissions, and marketing authorizations across UAE MOH, EU EMA, US FDA, and GCC authorities.
Supply Strategy
CMO/CDMO selection, contract manufacturing, sourcing, tech transfer, and supply-chain design.
Market Entry
Go-to-market strategy, distribution channels, government tenders, pricing, and commercial launch.
Founder
Built on decades of industry leadership
QANTARIS is led by Paulo Paiva dos Santos, the pharmaceutical entrepreneur who founded Generis in 2002 and grew it into Portugal’s largest pharmaceutical company.
A Harvard Business School and Oxford alumnus, Paulo scaled Generis from start-up to industrial powerhouse before its acquisition by the Aurobindo group. Today he splits his time between Lisbon and Dubai, where he serves as President of the Portuguese Business Council, established by Dubai Chambers.
The Paulo & Generis storyReady to begin?
Find a molecule. Or find a partner.
Search our molecule library, or talk to us about your regulatory, facility, manufacturing or market-entry project.